Wednesday, April 15, 2026
10:00 a.m. to 4:30 p.m. ET
Online Only
**The agenda is tentative and subject to change.**
« Back to Workshop Page
See Day 2: April 16, 2026 »
See Day 3: April 17, 2026 »»
Introductory Session
10:00 a.m.
Welcome
David M. Murray, Ph.D.
Associate Director for Prevention
Director, Office of Disease Prevention
Division of Program Coordination, Planning, and Strategic Initiatives
Office of the Director
National Institutes of Health
Director’s Remarks
10:05 a.m.
Office of Research on Women’s Health
Janine Austin Clayton, M.D., FARVO
Associate Director for Research on Women’s Health
Director, Office of Research on Women’s Health
Division of Program Coordination, Planning, and Strategic Initiatives
Office of the Director
National Institutes of Health
10:10 a.m.
National Institute on Aging
Richard J. Hodes, M.D.
Director, National Institute on Aging
National Institutes of Health
10:15 a.m.
Charge to the Panel
David M. Murray, Ph.D.
Office of Disease Prevention
National Institutes of Health
10:20 a.m.
Overview of Independent Panel Activities
Workshop & Panel Chair
10:30 a.m.
P2P Workshop Overview: Topic, Key Questions, Current National Institutes of Health Research, and Agency Perspectives
10:50 a.m.
Keynote Address: Understanding the Public Health Significance of the Menopausal Transition
- Basic Biology and Symptoms of Perimenopause—Nanette Santoro, M.D.
- Rationale and Lessons from the Women’s Health Initiative—JoAnn Manson, M.D., Dr.P.H., M.P.H.
11:40 a.m.
Discussion
Moderated by
Workshop & Panel Chair
Key Question 1:
What are the effectiveness, comparative effectiveness, and harms of treatments for menopausal symptoms in perimenopausal and early postmenopausal women?
12:00 p.m.
Evidence-based Practice Center Presentation I
1:00 p.m.
Lunch Break
Key Question 1a:
Do the effectiveness, comparative effectiveness, and harms of treatment vary by dose, delivery mode, formulation, or duration of treatment?
1:30 p.m.
Hormonal Therapies for Symptom Management—Susan Reed, M.D., M.P.H., M.S.
1:50 p.m.
Non-Hormonal Therapies for Symptom Management—JoAnn Pinkerton, M.D.
2:10 p.m.
Provider Considerations for Symptom Management—Cynthia Stuenkel, M.D.
2:30 p.m.
Discussion
Moderated by
Workshop & Panel Chair
2:50 p.m.
Break
General Session 1
Healthy Aging in Women: Supporting Overall Well-Being During the Menopause Transition—Part 1
3:00 p.m.
Moderator Perspectives—Karen Giblin
3:10 p.m.
Physical Activity and Management of Menopausal Symptoms—Sarah Witkowski, Ph.D.
3:25 p.m.
Nutritional Strategies and Perimenopause—Abbie Smith-Ryan, Ph.D.
3:40 p.m.
Hormonal Regulation of Metabolic Changes—Kerrie Moreau, Ph.D.
3:55 p.m.
Fatigue and Heavy Bleeding—Sioban Harlow, Ph.D.
4:10 p.m.
Discussion
Moderated by
Karen Giblin
4:30 p.m.
Adjourn